Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction. 2022

Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
Department of Cardiology, National University Heart Centre Singapore, Singapore 119074, Singapore.

Background: Patients with cancer are at increased risk of acute myocardial infarction (AMI). It is unclear if the Atherosclerotic Cardiovascular Disease (ASCVD) risk score at incident AMI is reflective of this higher risk in patients with prior cancer than those without. Methods: We linked nationwide AMI and cancer registries from 2008 to 2019. A total of 18,200 eligible patients with ASCVD risk score calculated at incident AMI were identified (1086 prior cancer; 17,114 no cancer). Results: At incident AMI, age-standardized mean ASCVD risk was lower in the prior cancer group (18.6%) than no cancer group (20.9%) (p < 0.001). Prior to incident AMI, smoking, hypertension, hyperlipidemia and diabetes mellitus were better controlled in the prior cancer group. However post-AMI, prior cancer was associated with lower guideline-directed medical therapy usage and higher all-cause mortality (adjusted hazard ratio 1.85, 95% confidence interval 1.66−2.07). Conclusions: AMI occurred despite better control of cardiovascular risk factors and lower age-standardized estimated mean 10-year ASCVD risk among patients with prior cancer than no cancer. Prior cancer was associated with lower guideline-directed medical therapy post-AMI and higher mortality.

UI MeSH Term Description Entries

Related Publications

Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
March 2021, Journal of diabetes and its complications,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
December 2020, Journal of clinical medicine,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
September 2022, The American journal of the medical sciences,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
September 2006, Journal of the American College of Cardiology,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
January 2021, Gaceta medica de Mexico,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
April 2020, JAMA network open,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
May 2019, Journal of the American Heart Association,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
December 2020, European journal of preventive cardiology,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
January 2022, Frontiers in cardiovascular medicine,
Chieh Yang Koo, and Huili Zheng, and Li Ling Tan, and Ling-Li Foo, and Derek J Hausenloy, and Wee-Joo Chng, and Soo Chin Lee, and Arthur Mark Richards, and Lieng-Hsi Ling, and Shir Lynn Lim, and Chi-Hang Lee, and Mark Y Chan
November 2021, Journal of the American Heart Association,
Copied contents to your clipboard!